Stock listing
NASDAQ:AMAM Ambrx Biopharma Inc. Stock
Follow Ambrx Biopharma Inc. into a list and get an email when it puts out news.
Last close · NASDAQ:AMAM
$28.00 USD
Close on Mar 6, 2024 · No longer trades
- Lowest – highest close
- $0.41 – $28.09 USDSince Jun 18, 2021 · lowest Dec 8, 2022 · highest Jan 11, 2024
Delisted NASDAQ:AMAM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:AMAM
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Ambrx Biopharma Inc. on 6ix
- Decks
- 5 decks · latest Feb 15, 2024
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (February 2024) | Merger or acquisition | 18 slides | Feb 15, 2024 |
| Investor Presentation (April 2023) | Investor deck | 32 slides | Apr 10, 2023 |
| Investor Day (February 2023) | Investor day | 19 slides | Feb 24, 2023 |
| Corporate Update (October 2022) | Corporate update | 21 slides | Oct 18, 2022 |
| Investor Presentation (November 2021) | Investor deck | 31 slides | Nov 8, 2021 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Daniel O’Connor Other companies: DiaMedica Therapeutics Inc. (Director · Since at least Feb 20, 2025); ZyVersa Therapeutics, Inc. (Director · Dec 20, 2021 – Dec 12, 2022 · Past) | President and CEO, Director · Jan 1, 2023 – Mar 7, 2024 · Past |
| Paul V. Maier Other companies: International Stem Cell Corporation (Director · Since at least Jun 9, 2021); Eton Pharmaceuticals, Inc. (Eton Pharmaceutical Audit Committee Chairman · Since at least May 3, 2021) | Director · Jan 1, 2023 – Mar 7, 2024 · Past |
| Sonja Nelson Other companies: Motus GI Holdings, Inc. (Director · Jun 22, 2021 – Mar 5, 2024 · Past); ImmunityBio, Inc. (Chief Financial Officer · Aug 2, 2019 – Jan 12, 2021 · Past) | Chief Financial Officer · Jan 1, 2023 – Mar 7, 2024 · Past |
| Andrew Aromando Other companies: Oncolytics Biotech Inc. (Chief Business Officer · Since at least Jun 30, 2025) | Chief Operating Officer · Apr 28, 2023 – Mar 7, 2024 · Past |
| Margaret Dalesandro Other companies: Skye Bioscience, Inc. (Director · Sep 14, 2021 – Feb 29, 2024 · Past) | Director · Sep 1, 2023 – Mar 7, 2024 · Past |
| Janet Loesberg | Director · Mar 7, 2024 – Mar 7, 2024 · Past |
| Kate Hermans | Director · Jan 1, 2023 – Mar 7, 2024 · Past |
| Xiaowei Chang | Director · Jan 1, 2023 – Jun 7, 2023 · Past |
Log in to ask 6ix AI your own questions about Ambrx Biopharma Inc.